Ji Hyong Hong

Catholic University of Korea - Department of Medicine

Yeok Kok 2 Dong San 43-1

Won Mi Ku

Bucheon

Korea, Republic of (South Korea)

SCHOLARLY PAPERS

1

DOWNLOADS

46

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

Capecitabine Plus Oxaliplatin Versus Gemcitabine Plus Oxaliplatin as First-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Randomized, Phase Three, Non-Inferiority Trial

Number of pages: 60 Posted: 09 Aug 2018
Sungkyunkwan University - Department of Medicine, Gyeongsang National University - Department of Medicine, Sungkyunkwan University - Division of Hematology-Oncology, Ajou University - Department of Medicine, Dong-A University - Department of Medicine, Chung-Ang University, College of Medicine, Department of Medicine, Catholic University of Korea - Department of Medicine, Inje University - Department of Medicine, Konkuk University - Department of Medicine, Yonsei University - Department of Medicine, Catholic University of Korea - Department of Medicine, Sungkyunkwan University - Statistics and Data CenterSungkyunkwan University - Department of Ophthalmology, Sungkyunkwan University - Statistics and Data Center, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - Department of Medicine and Sungkyunkwan University - Department of Medicine
Downloads 46 (880,427)
Citation 1

Abstract:

Loading...

biliary tract cancer, capecitabine, oxaliplatin, gemcitabine